SCHEMBL29892803

SCHEMBL29892803

Cc1cc2ccc(Br)cc2[nH]c1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 1/20 0.59
▸ DAO P14920 2/20 0.46
▸ DDO Q99489 1/20 0.46
▸ METAP2 P50579 1/20 0.43
▸ TYMS P04818 1/20 0.43
▸ HRH4 Q9H3N8 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ GRIN2D O15399 1/20 0.42
▸ GRIN3B O60391 1/20 0.42
▸ GRIN1 Q05586 1/20 0.42
▸ GRIN2A Q12879 1/20 0.42
▸ GRIN2B Q13224 1/20 0.42
▸ GRIN2C Q14957 1/20 0.42
▸ GRIN3A Q8TCU5 1/20 0.42
▸ TP53 P04637 1/20 0.41
▸ AHR P35869 1/20 0.41
▸ ATAD2 Q6PL18 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13802346 0.85 BRD4 (0.59) BRD4DAOHRH4LMNAHPGD
SCHEMBL16627567 0.81 METAP2 (0.46) DAODDOMETAP2HRH4TP53
SCHEMBL15478601 0.81 DAO (0.68) BRD4DAODDOLMNAHPGD
SCHEMBL25317005 0.79 ALDH1A1 (0.49) DAOLMNAHPGDMAPTGRIN2D
SCHEMBL15690449 0.78 DAO (0.64) DAODDOMETAP2
SCHEMBL1438376 0.78 BRD4 (0.59) BRD4DAODDOTYMSGRIN2D
SCHEMBL1038241 0.78 BRD4 (0.59) BRD4DAODDOHRH4HPGD
SCHEMBL1709827 0.78 BRD4 (0.59) BRD4DAODDOHRH4HPGD
SCHEMBL12970589 0.78 DAO (0.64) BRD4DAODDOTYMSGRIN2D
SCHEMBL4388117 0.78 DAO (0.64) BRD4DAODDOLMNAGRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4313308-A1 TEAD INHIBITORS AND USES THEREOF Cedilla Therapeutics, Inc. (US) 2024-02-07 — — EP disclosed
WO-2022204452-A1 TEAD INHIBITORS AND USES THEREOF CEDILLA THERAPEUTICS, INC. (US) 2022-09-29 — — WO disclosed
Send feedback